M&A Deal Summary

Merck Acquires Rosetta Inpharmatics

On May 11, 2001, Merck acquired life science company Rosetta Inpharmatics from Perseus for 620M USD

Acquisition Highlights
  • This is Merck’s 3rd transaction in the Life Science sector.
  • This is Merck’s 15th largest (disclosed) transaction.
  • This is Merck’s 3rd transaction in the United States.
  • This is Merck’s 1st transaction in Washington.

M&A Deal Summary
Date 2001-05-11
Target Rosetta Inpharmatics
Sector Life Science
Buyer(s) Merck
Sellers(s) Perseus
Deal Type Add-on Acquisition
Deal Value 620M USD

Target

Rosetta Inpharmatics

Kirkland, Washington, United States
Rosetta Inpharmatics, Inc. is a developer of new technologies for drug discovery that allow high-throughput screening of potential therapeutic compounds for their effects on cells.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Merck

Rahway, New Jersey, United States
Category Company
Founded 1891
Sector Life Science
Employees70,000
Revenue 60.1B USD (2023)
DESCRIPTION
Merck office in Palo Alto, California.
Merck office in Palo Alto, California.

Merck is a global healthcare company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The Company’s operations are comprised of four operating segments. These include Pharmaceutical, Animal Health, Consumer Care and Alliances. Merck's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company also has animal health operations that discover, develop, manufacture and market animal health products, including vaccines, which the Company sells to veterinarians, distributors and animal producers. Additionally, the Company has consumer care operations that develop, manufacture and market over-the-counter, foot care and sun care products. Merck was established in 1891 and is based in Rahway, New Jersey.

DEAL STATS #
Overall 4 of 35
Sector (Life Science) 3 of 32
Type (Add-on Acquisition) 4 of 33
State (Washington) 1 of 2
Country (United States) 3 of 27
Year (2001) 1 of 1
Size (of disclosed) 15 of 27
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2000-06-19 ProVantage Health Service

Waukesha,, Wisconsin, United States

ProVantage Health Service, provides health information technology, health benefit management services, pharmacy mail services, vision benefit management services, and clinical support services.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-05-09 Abmaxis

Santa Clara, California, United States

Abmaxis, Inc. is a privately-held biopharmaceutical company dedicated to the discovery, optimization and development of monoclonal antibody (MAb) products for human therapeutics and diagnostics. Abmaxis has developed and validated a breakthrough antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM), which is used for building an internal product pipeline and for collaborations with global biotech and pharmaceutical partners. The Company's investors include New World Genomics Ltd. and Y's Therapeutics. Abmaxis is located in Santa Clara, California.

Buy $80M

Seller(S) 1

SELLER

Perseus

Washington, District of Columbia, United States
Category Merchant Bank
Founded 1995
PE ASSETS 2.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Perseus is a private equity firm focused on middle-market buyouts, recapitalizations, and growth equity investments. Perseus looks businesses operating with proven management, strong brands, and 'powerful intellectual property'. Sectors of interest include biotechnology, medical devices, branded consumer products, business services, information technology, communications, and energy/environmental service companies. Perseus was formed in 1995 and maintains offices in Washington DC, New York City, and Munich.

DEAL STATS #
Overall 9 of 31
Sector (Life Science) 3 of 5
Type (Add-on Acquisition) 7 of 22
State (Washington) 1 of 2
Country (United States) 9 of 27
Year (2001) 1 of 2
Size (of disclosed) 2 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2001-01-01 Raleigh Cycle Limited

Kent, Washington, United States

Raleigh Cycle is a US-based designer, manufacturer and marketer of bicycles.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2001-07-30 Chroma Energy

Houston, Texas, United States

Chroma Energy, Inc. is an analyzes oil and gas drilling prospects using its proprietary technology an advanced analytical and interpretive technology that recognizes geologically significant patterns in seismic data.

Buy -
Mergr

Product

Company

Legal